Mary Malec

3.8k total citations
34 papers, 3.0k citations indexed

About

Mary Malec is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mary Malec has authored 34 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 16 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Mary Malec's work include Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (14 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Mary Malec is often cited by papers focused on Glioma Diagnosis and Treatment (24 papers), Brain Metastases and Treatment (14 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Mary Malec collaborates with scholars based in United States, Austria and Japan. Mary Malec's co-authors include Michael D. Prados, Kathleen R. Lamborn, Philip H. Gutin, David A. Larson, Penny K. Sneed, William M. Wara, Susan M. Chang, Charles B. Wilson, Keith A. Weaver and Michael W. McDermott and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Mary Malec

34 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Malec United States 24 1.9k 969 718 645 533 34 3.0k
Sara Erridge United Kingdom 24 1.7k 0.9× 990 1.0× 674 0.9× 652 1.0× 515 1.0× 67 3.0k
Dorcas Fulton Canada 27 2.4k 1.3× 1.2k 1.3× 1.0k 1.4× 499 0.8× 481 0.9× 42 3.5k
Minhee Won United States 26 2.0k 1.1× 1.4k 1.4× 560 0.8× 504 0.8× 527 1.0× 63 3.5k
Baldassarre Stea United States 28 877 0.5× 1.4k 1.4× 503 0.7× 566 0.9× 1.0k 1.9× 117 3.1k
Urs M. Lütolf Switzerland 26 1.1k 0.6× 1.4k 1.4× 715 1.0× 819 1.3× 683 1.3× 50 3.4k
Alicia Tosoni Italy 29 2.9k 1.6× 1.3k 1.3× 1.1k 1.5× 799 1.2× 771 1.4× 103 4.2k
Tony J. C. Wang United States 27 858 0.5× 1.2k 1.2× 555 0.8× 440 0.7× 549 1.0× 114 2.5k
Wenyin Shi United States 30 1.3k 0.7× 1.7k 1.8× 661 0.9× 595 0.9× 832 1.6× 181 3.4k
Ashwatha Narayana United States 29 1.2k 0.6× 1.3k 1.3× 485 0.7× 484 0.8× 808 1.5× 64 3.0k
Joshua D. Palmer United States 26 1.0k 0.5× 1.1k 1.1× 561 0.8× 387 0.6× 623 1.2× 189 2.7k

Countries citing papers authored by Mary Malec

Since Specialization
Citations

This map shows the geographic impact of Mary Malec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Malec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Malec more than expected).

Fields of papers citing papers by Mary Malec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Malec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Malec. The network helps show where Mary Malec may publish in the future.

Co-authorship network of co-authors of Mary Malec

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Malec. A scholar is included among the top collaborators of Mary Malec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Malec. Mary Malec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haas-Kogan, Daphne A., Michael D. Prados, Tarık Tihan, et al.. (2005). Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib. JNCI Journal of the National Cancer Institute. 97(12). 880–887. 368 indexed citations
2.
Chang, Susan M., Kathleen R. Lamborn, Mary Malec, et al.. (2004). Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 60(2). 353–357. 117 indexed citations
3.
Chang, Susan M., Philip V. Theodosopoulos, Kathleen R. Lamborn, et al.. (2004). Temozolomide in the treatment of recurrent malignant glioma. Cancer. 100(3). 605–611. 67 indexed citations
4.
Homoncik, Monika, Mary Malec, Claudia Marsik, et al.. (2003). Rofecoxib exerts no effect on platelet plug formation in healthy volunteers.. PubMed. 21(2). 229–31. 11 indexed citations
5.
Prados, Michael D., William M. Wara, Penny K. Sneed, et al.. (2001). Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 49(1). 71–77. 108 indexed citations
6.
Levin, V. A., Kathleen R. Lamborn, William M. Wara, et al.. (2000). Phase II study of 6-thioguanine, procarbazine, dibromodulcitol,lomustine, and vincristine chemotherapy with radiotherapy for treatingmalignant glioma in children. Neuro-Oncology. 2(1). 22–28. 7 indexed citations
7.
Chang, Susan M., John G. Kuhn, Jinee Rizzo, et al.. (1998). Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.. Journal of Clinical Oncology. 16(6). 2188–2194. 131 indexed citations
8.
Sneed, Penny K., Paul R. Stauffer, Michael McDermott, et al.. (1998). Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 40(2). 287–295. 276 indexed citations
9.
Prados, Michael D., et al.. (1996). Intravenous Carboplatin for Recurrent Gliomas. American Journal of Clinical Oncology. 19(6). 609–612. 40 indexed citations
10.
Sneed, Penny K., Carolyn Russo, Michael D. Prados, et al.. (1996). Long-Term Follow-Up after High-Activity <sup>125</sup>I Brachytherapy for Pediatric Brain Tumors. Pediatric Neurosurgery. 24(6). 314–322. 15 indexed citations
11.
Sneed, Penny K., Paul R. Stauffer, Chris J. Diederich, et al.. (1996). Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. International Journal of Radiation Oncology*Biology*Physics. 36(1). 159–159. 259 indexed citations
12.
Barker, Fred G., Michael D. Prados, Susan M. Chang, et al.. (1996). Radiation response and survival time in patients with glioblastoma multiforme. Journal of neurosurgery. 84(3). 442–448. 130 indexed citations
13.
Sneed, Penny K., Michael D. Prados, Michael W. McDermott, et al.. (1995). Large Effect of Age on the Survival of Patients with Glioblastoma Treated with Radiotherapy and Brachytherapy Boost. Neurosurgery. 36(5). 898–904. 61 indexed citations
14.
Sneed, Penny K., Michael D. Prados, Michael W. McDermott, et al.. (1995). Large Effect of Age on the Survival of Patients with Glioblastoma Treated with Radiotherapy and Brachytherapy Boost. Neurosurgery. 36(5). 898???904–898???904. 5 indexed citations
15.
Prados, Michael D., Kathleen R. Lamborn, Janet Wynne, et al.. (1994). Proliferative potential and prognostic evaluation of low-grade astrocytomas. Journal of Neuro-Oncology. 19(1). 1–9. 38 indexed citations
16.
Sneed, Penny K., Philip H. Gutin, David A. Larson, et al.. (1994). Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. International Journal of Radiation Oncology*Biology*Physics. 29(4). 719–727. 165 indexed citations
17.
Levin, Victor A., Michael D. Prados, W.K. Alfred Yung, et al.. (1992). Treatment of Recurrent Gliomas With Eflornithine. JNCI Journal of the National Cancer Institute. 84(18). 1432–1437. 52 indexed citations
18.
Prados, Michael D., Philip H. Gutin, Theodore L. Phillips, et al.. (1992). Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience. International Journal of Radiation Oncology*Biology*Physics. 24(4). 593–597. 90 indexed citations
19.
Gandara, David R., Edith A. Perez, Vincent Caggiano, et al.. (1990). High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group. Cancer Chemotherapy and Pharmacology. 27(3). 243–247. 12 indexed citations
20.
Grosser, Stella, et al.. (1988). Body size, reproductive factors, and breast cancer survival. Preventive Medicine. 17(5). 634–642. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026